- Published on
Diagnostic Tests – Progesterone Challenge Test
1. For which clinical scenario(s) is this the best test?
The progesterone challenge test is used in the evaluation of amenorrhea after pregnancy has been excluded with a negative hCG test. It is most appropriate for a woman who has absent menstrual periods and helps determine whether amenorrhea is due to outflow tract obstruction or dysfunction at the level of the hypothalamus or pituitary. The test typically involves administering oral progesterone (about 10 mg daily for 5 days).
2. If bleeding occurs after the challenge, what does it indicate?
If withdrawal bleeding occurs, this indicates that:
This finding suggests that the amenorrhea is not due to an anatomic obstruction.
3. What is the next best test if bleeding occurs?
If bleeding occurs, the next step is to evaluate for hypothalamic or pituitary causes of amenorrhea. This is done by checking:
These tests help identify endocrine disorders such as hyperprolactinemia, hypothyroidism, or gonadotropin abnormalities.
4. If there is no bleeding, what is the next best test?
If no withdrawal bleeding occurs, this suggests either insufficient estrogen or an outflow tract obstruction. The next best step is to evaluate the reproductive anatomy, starting with pelvic ultrasound. If ultrasound findings are inconclusive, MRI is used to further assess for structural abnormalities or obstruction of the uterine outflow tract.
1. For which clinical scenario(s) is this the best test?
The progesterone challenge test is used in the evaluation of amenorrhea after pregnancy has been excluded with a negative hCG test. It is most appropriate for a woman who has absent menstrual periods and helps determine whether amenorrhea is due to outflow tract obstruction or dysfunction at the level of the hypothalamus or pituitary. The test typically involves administering oral progesterone (about 10 mg daily for 5 days).
2. If bleeding occurs after the challenge, what does it indicate?
If withdrawal bleeding occurs, this indicates that:
- Estrogen levels are adequate to build up the endometrial lining
- The uterus and outflow tract are intact and patent
This finding suggests that the amenorrhea is not due to an anatomic obstruction.
3. What is the next best test if bleeding occurs?
If bleeding occurs, the next step is to evaluate for hypothalamic or pituitary causes of amenorrhea. This is done by checking:
- FSH
- LH
- Prolactin
- TSH
These tests help identify endocrine disorders such as hyperprolactinemia, hypothyroidism, or gonadotropin abnormalities.
4. If there is no bleeding, what is the next best test?
If no withdrawal bleeding occurs, this suggests either insufficient estrogen or an outflow tract obstruction. The next best step is to evaluate the reproductive anatomy, starting with pelvic ultrasound. If ultrasound findings are inconclusive, MRI is used to further assess for structural abnormalities or obstruction of the uterine outflow tract.
- Published on
Diagnostic Tests – Metaiodobenzylguanidine (MIBG) Scan
1. What disease is this test for?
The metaiodobenzylguanidine (MIBG) scan is used to detect pheochromocytoma, particularly when the tumor is occult or not visualized on standard imaging. It is not a screening test; instead, it is used after biochemical confirmation of catecholamine excess (elevated metanephrines, catecholamines, or VMA) when CT or MRI fails to localize the tumor.
2. How is the test done?
MIBG, a compound structurally similar to norepinephrine, is injected intravenously. Because pheochromocytomas arise from adrenergic tissue, they actively take up MIBG. Nuclear imaging is then performed to visualize areas of tracer accumulation, allowing identification of adrenal or extra-adrenal catecholamine-secreting tumors.
3. When do you answer an MIBG scan?
You should select an MIBG scan in a patient who has:
This test is essential because a pheochromocytoma cannot be surgically cured unless it is accurately localized.
1. What disease is this test for?
The metaiodobenzylguanidine (MIBG) scan is used to detect pheochromocytoma, particularly when the tumor is occult or not visualized on standard imaging. It is not a screening test; instead, it is used after biochemical confirmation of catecholamine excess (elevated metanephrines, catecholamines, or VMA) when CT or MRI fails to localize the tumor.
2. How is the test done?
MIBG, a compound structurally similar to norepinephrine, is injected intravenously. Because pheochromocytomas arise from adrenergic tissue, they actively take up MIBG. Nuclear imaging is then performed to visualize areas of tracer accumulation, allowing identification of adrenal or extra-adrenal catecholamine-secreting tumors.
3. When do you answer an MIBG scan?
You should select an MIBG scan in a patient who has:
- Symptoms suggestive of pheochromocytoma (e.g., palpitations, episodic hypertension, intermittent tachycardia, diaphoresis)
- Positive biochemical testing (elevated catecholamines, metanephrines, or VMA)
- Negative or nondiagnostic CT or MRI
This test is essential because a pheochromocytoma cannot be surgically cured unless it is accurately localized.
- Published on
Diagnostic Tests – 5-HIAA (5-Hydroxyindoleacetic Acid)
1. What is this test?
A 24-hour urine 5-HIAA level measures 5-hydroxyindoleacetic acid, the primary end-product of serotonin metabolism. It is the best initial diagnostic test for carcinoid syndrome, reflecting excess serotonin production by neuroendocrine tumors.
2. When do you answer a 5-HIAA level?
You should choose a 5-HIAA test when a patient presents with episodic symptoms suggestive of carcinoid syndrome, including:
The combination of flushing plus diarrhea is particularly high-yield for test questions.
3. What is the most accurate diagnostic test?
The most accurate diagnostic test for carcinoid syndrome is a biopsy with histologic confirmation. While CT and MRI scans can help localize tumors or metastases, they are not as definitive as tissue diagnosis obtained through biopsy.
1. What is this test?
A 24-hour urine 5-HIAA level measures 5-hydroxyindoleacetic acid, the primary end-product of serotonin metabolism. It is the best initial diagnostic test for carcinoid syndrome, reflecting excess serotonin production by neuroendocrine tumors.
2. When do you answer a 5-HIAA level?
You should choose a 5-HIAA test when a patient presents with episodic symptoms suggestive of carcinoid syndrome, including:
- Recurrent watery diarrhea
- Unexplained flushing
- Wheezing or bronchospasm
- Episodic hypotension
The combination of flushing plus diarrhea is particularly high-yield for test questions.
3. What is the most accurate diagnostic test?
The most accurate diagnostic test for carcinoid syndrome is a biopsy with histologic confirmation. While CT and MRI scans can help localize tumors or metastases, they are not as definitive as tissue diagnosis obtained through biopsy.
- Published on
Diagnostic Tests – Fine-Needle Aspiration (FNA) of the Thyroid
1. What is this test?
Fine-needle aspiration (FNA) of the thyroid is a minimally invasive procedure in which a thin needle is used to obtain a sample of thyroid cells for cytologic examination. It is the initial diagnostic test of choice for most solitary thyroid nodules, as it helps determine whether a nodule is benign or malignant.
2. When is this the most accurate test?
FNA is the most appropriate and accurate next step when a patient has:
In exam questions, if a euthyroid patient with a thyroid nodule is described and the question asks for the next step in diagnosis, the correct answer is typically fine-needle aspiration.
3. When is this the wrong answer?
FNA is not the correct initial test in patients with a solitary thyroid nodule who are thyrotoxic (suppressed TSH, elevated T3/T4). In this scenario, a thyroid scintigraphy (radioiodine uptake scan) should be performed first to determine whether the nodule is:
1. What is this test?
Fine-needle aspiration (FNA) of the thyroid is a minimally invasive procedure in which a thin needle is used to obtain a sample of thyroid cells for cytologic examination. It is the initial diagnostic test of choice for most solitary thyroid nodules, as it helps determine whether a nodule is benign or malignant.
2. When is this the most accurate test?
FNA is the most appropriate and accurate next step when a patient has:
- A palpable solitary thyroid nodule
- Normal thyroid function tests (euthyroid state)
In exam questions, if a euthyroid patient with a thyroid nodule is described and the question asks for the next step in diagnosis, the correct answer is typically fine-needle aspiration.
3. When is this the wrong answer?
FNA is not the correct initial test in patients with a solitary thyroid nodule who are thyrotoxic (suppressed TSH, elevated T3/T4). In this scenario, a thyroid scintigraphy (radioiodine uptake scan) should be performed first to determine whether the nodule is:
- Hyperfunctioning (“hot”) — almost never malignant
- Hypofunctioning (“cold”) — higher risk of malignancy and may then require FNA
- Published on
Diagnostic Tests – Excision Skin Biopsy
1. For which clinical scenario(s) is this diagnostic tool indicated?
An excision skin biopsy is a diagnostic technique in which the entire skin lesion is removed with full thickness, ideally in one intact specimen. It is indicated when there is high clinical suspicion for malignancy, particularly when accurate assessment of lesion depth, margins, and architecture is required for diagnosis and staging.
2. For which condition is this test always the right answer?
An excision biopsy is always the correct diagnostic test for suspected malignant melanoma. Melanoma requires complete removal of the lesion to allow proper evaluation of Breslow depth, which is critical for staging and prognosis. Partial biopsies (such as shave or punch biopsies) are inadequate because they may prevent accurate staging and risk underestimating tumor depth.
Key exam pearl: If melanoma is suspected, excision biopsy is the answer—always.
1. For which clinical scenario(s) is this diagnostic tool indicated?
An excision skin biopsy is a diagnostic technique in which the entire skin lesion is removed with full thickness, ideally in one intact specimen. It is indicated when there is high clinical suspicion for malignancy, particularly when accurate assessment of lesion depth, margins, and architecture is required for diagnosis and staging.
2. For which condition is this test always the right answer?
An excision biopsy is always the correct diagnostic test for suspected malignant melanoma. Melanoma requires complete removal of the lesion to allow proper evaluation of Breslow depth, which is critical for staging and prognosis. Partial biopsies (such as shave or punch biopsies) are inadequate because they may prevent accurate staging and risk underestimating tumor depth.
Key exam pearl: If melanoma is suspected, excision biopsy is the answer—always.
- Published on
Diagnostic Tests – Direct Immunofluorescence (DIF) of Skin Biopsy
1. For which clinical condition(s) is this the most accurate test?
Direct immunofluorescence (DIF) is the most accurate diagnostic test for immunologic blistering skin disorders, particularly:
It is also used for other immune-mediated dermatoses where antibody or complement deposition patterns are diagnostic.
2. When is this test the best initial step?
DIF is the best initial diagnostic step when a patient presents with:
The test is performed on a skin biopsy taken from perilesional (normal-appearing) skin, not from the blister itself.
DIF evaluates the presence and pattern of deposition of:
Management depends on the diagnosis confirmed by DIF:
1. For which clinical condition(s) is this the most accurate test?
Direct immunofluorescence (DIF) is the most accurate diagnostic test for immunologic blistering skin disorders, particularly:
- Pemphigus vulgaris
- Bullous pemphigoid
It is also used for other immune-mediated dermatoses where antibody or complement deposition patterns are diagnostic.
2. When is this test the best initial step?
DIF is the best initial diagnostic step when a patient presents with:
- Blistering skin disease
- Suspicion of an autoimmune etiology
- Findings such as fragile bullae, mucosal involvement, or tense blisters
The test is performed on a skin biopsy taken from perilesional (normal-appearing) skin, not from the blister itself.
DIF evaluates the presence and pattern of deposition of:
- IgG
- IgM
- IgA
- C3
- Fibrinogen
Management depends on the diagnosis confirmed by DIF:
- Pemphigus vulgaris
- DIF finding: IgG and C3 between epidermal cells (fish-net pattern)
- Treatment: Systemic corticosteroids ± immunosuppressants
- Bullous pemphigoid
- DIF finding: IgG and C3 at the dermoepidermal junction (linear pattern)
- Treatment: Topical or systemic corticosteroids, depending on severity
- Published on
Diagnostic Tests – Skin Scraping and Mineral Oil Mount
1. What is this test?
A skin scraping with mineral oil mount is a bedside diagnostic test used to identify scabies. Mineral oil is applied to the suspected lesion to enhance visualization of the burrow. The skin is then scraped and examined under a microscope. The mineral oil preserves skin cells, mite feces (scybala), and allows mites to remain intact and motile, improving diagnostic yield.
2. When is this the answer?
This test is indicated when a patient presents with:
In exam questions, the combination of pruritus + burrows + web-space involvement should immediately point to scabies, making skin scraping with mineral oil the correct diagnostic choice.
3. What is an adjuvant test often used in the same scenario?
A commonly used adjunct test is a KOH wet mount prepared from the same skin scrapings. The slide is gently heated to dissolve keratin and break up squamous cells, helping reveal mites that may be hidden beneath debris.
1. What is this test?
A skin scraping with mineral oil mount is a bedside diagnostic test used to identify scabies. Mineral oil is applied to the suspected lesion to enhance visualization of the burrow. The skin is then scraped and examined under a microscope. The mineral oil preserves skin cells, mite feces (scybala), and allows mites to remain intact and motile, improving diagnostic yield.
2. When is this the answer?
This test is indicated when a patient presents with:
- Intensely pruritic rash, often worse at night
- Small linear burrows, especially in the web spaces of the hands and feet
- Possible involvement of genitalia or breasts
- A history suggesting close personal or sexual contact
In exam questions, the combination of pruritus + burrows + web-space involvement should immediately point to scabies, making skin scraping with mineral oil the correct diagnostic choice.
3. What is an adjuvant test often used in the same scenario?
A commonly used adjunct test is a KOH wet mount prepared from the same skin scrapings. The slide is gently heated to dissolve keratin and break up squamous cells, helping reveal mites that may be hidden beneath debris.
- Published on
Diagnostic Tests – Wood’s Light Examination
1. What is this?
A Wood’s light examination is a noninvasive dermatologic test that uses ultraviolet (UV) light (~365 nm) to examine the skin, hair, and nails in a dark room. Certain organisms and skin conditions fluoresce under UV light, helping clinicians narrow the differential diagnosis of infectious and pigmentary disorders.
2. What are some organisms or conditions that fluoresce under Wood’s light?
Characteristic fluorescence patterns include
1. What is this?
A Wood’s light examination is a noninvasive dermatologic test that uses ultraviolet (UV) light (~365 nm) to examine the skin, hair, and nails in a dark room. Certain organisms and skin conditions fluoresce under UV light, helping clinicians narrow the differential diagnosis of infectious and pigmentary disorders.
2. What are some organisms or conditions that fluoresce under Wood’s light?
Characteristic fluorescence patterns include
- Erythrasma (Corynebacterium minutissimum)
→ Coral-red fluorescence - Tinea capitis (some Microsporum species)
→ Blue-green fluorescence - Pseudomonas aeruginosa
→ Green fluorescence - Vitiligo
→ Bright blue-white accentuation - Tinea versicolor (Malassezia)
→ Yellowish or coppery fluorescence (may be subtle or absent)
- Published on
Diagnostic Tests – Arthrocentesis
1. What is this?
Arthrocentesis is a procedure in which synovial fluid is aspirated from a joint using a needle for laboratory and microscopic analysis. It is the most accurate immediate test to distinguish between:
2. When do you answer arthrocentesis?
You should answer arthrocentesis when a patient presents with:
This is especially critical when infection must be ruled out. In cases of suspected gout, serum uric acid may be elevated, but arthrocentesis is still required to confirm the diagnosis and exclude infection.
Exam pearl:
Any new, hot, swollen joint = arthrocentesis first
3. What findings are evident in the two synovial fluid samples?
Microscopic examination under polarized light reveals characteristic crystals:
1. What is this?
Arthrocentesis is a procedure in which synovial fluid is aspirated from a joint using a needle for laboratory and microscopic analysis. It is the most accurate immediate test to distinguish between:
- Normal joint fluid
- Inflammatory arthritis
- Septic (infectious) arthritis
- 0–2,000 cells/µL → Normal
- 2,000–20,000 cells/µL → Inflammatory (e.g., gout, rheumatoid arthritis)
- 20,000–50,000 cells/µL → Indeterminate
- >50,000 cells/µL → Septic arthritis
2. When do you answer arthrocentesis?
You should answer arthrocentesis when a patient presents with:
- Acute onset of a swollen joint
- Warmth, pain, and tenderness
- Joint effusion with decreased range of motion
This is especially critical when infection must be ruled out. In cases of suspected gout, serum uric acid may be elevated, but arthrocentesis is still required to confirm the diagnosis and exclude infection.
Exam pearl:
Any new, hot, swollen joint = arthrocentesis first
3. What findings are evident in the two synovial fluid samples?
Microscopic examination under polarized light reveals characteristic crystals:
- Gout
- Negatively birefringent
- Needle-shaped crystals
- Composed of monosodium urate
- Pseudogout
- Positively birefringent
- Rhomboid-shaped crystals
- Composed of calcium pyrophosphate
- Published on
Diagnostic Tests – Patch Testing
1. For which clinical scenario(s) is this test indicated?
Patch testing is indicated in patients with suspected allergic contact dermatitis when:
The rash is chronic or recurrent
2. What important distinction must be made before utilizing this test?
Before performing patch testing, it is critical to distinguish between:
Patch testing is NOT useful for irritant contact dermatitis, because irritant reactions do not involve an immune response.
Patch testing should only be used when allergic contact dermatitis is suspected.
1. For which clinical scenario(s) is this test indicated?
Patch testing is indicated in patients with suspected allergic contact dermatitis when:
The rash is chronic or recurrent
- The suspected offending agent has already been removed
- Topical therapy (e.g., corticosteroids, emollients) has failed
- The clinician needs to identify the specific allergen responsible for the dermatitis
2. What important distinction must be made before utilizing this test?
Before performing patch testing, it is critical to distinguish between:
- Allergic contact dermatitis (immune-mediated, type IV hypersensitivity)
- Irritant contact dermatitis (non-immunologic, due to direct chemical or physical damage
Patch testing is NOT useful for irritant contact dermatitis, because irritant reactions do not involve an immune response.
Patch testing should only be used when allergic contact dermatitis is suspected.
